ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

SenExo-cCCT2 Reprograms Senescence Response and Anti-Tumor Immunity Following FOLFIRINOX Chemotherapy in Pancreatic Ductal Adenocarcinoma.

Shuncang Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.